Arrow
Arrow
Slider

Publikacje Projektowe

New insights into redox homeostasis as a therapeutic target in B-cell malignancies.

Graczyk-Jarzynka A, Zagozdzon R, Muchowicz A, Siernicka M, Juszczynski P, Firczuk M.

Curr Opin Hematol. 2017 Jul 24

https://www.ncbi.nlm.nih.gov/pubmed/28402987

 

Iterative Sequencing and Variant Screening (ISVS) as a novel pathogenic mutations search strategy - application for TMPRSS3 mutations screen.

Lechowicz U, Gambin T, Pollak A, Podgorska A, Stawinski P, Franke A, Petersen BS, Firczuk M, Oldak M, Skarzynski H, Ploski R.

Scie Rep. 2017 May 31

https://www.ncbi.nlm.nih.gov/pubmed/28566687

 

Co-delivery of indoleamine 2,3-dioxygenase prevents loss of expression of an antigenic transgene in dystrophic mouse muscles.

Sharma D, Al-Khalidi R, Edgar S, An Q, Wang Y, Young C, Nowis D, Gorecki DC.

Gene Ther. 2017 Feb 24

https://www.ncbi.nlm.nih.gov/pubmed/28004656

 

Dissection of CD20 regulation in lymphoma using RNAi.

Słabicki M, Lee KS, Jethwa A, Sellner L, Sacco F, Walther T, Hüllein J, Dietrich S, Wu B, Lipka DB, Oakes CC, Mamidi S, Pyrzyńska B, Winiarska M, Oleś M, Seifert M, Plass C, Kirschfink M, Mann M, Boettcher M, Golab J, Huber W, Fröhling S, Zenz T.

Leukemia. 2016 Aug 18

http://www.ncbi.nlm.nih.gov/pubmed/27560109

 

BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199.
Bojarczuk K, Sasi BK, Gobessi S, Innocenti I, Pozzato G, Laurenti L, Efremov DG.

Blood. 2016 Jun 23

http://www.ncbi.nlm.nih.gov/pubmed/27095788

 

MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy.
Polak A, Kiliszek P, Sewastianik T, Szydłowski M, Jabłońska E, Białopiotrowicz E, Górniak P, Markowicz S, Nowak E, Grygorowicz MA, Prochorec-Sobieszek M, Nowis D, Gołąb J, Giebel S, Lech-Marańda E, Warzocha K, Juszczyński P.

PLoS One. 2016 May 19

http://www.ncbi.nlm.nih.gov/pubmed/27196001

 

The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development.

Stachura J, Wachowska M, Kilarski WW, Güç E, Golab J, Muchowicz A.

Oncoimmunology. 2016 May 13

http://www.ncbi.nlm.nih.gov/pubmed/27622039

 

An Interplay of S-Nitrosylation and Metal Ion Binding for Astrocytic S100B Protein.
Bajor M, Zaręba-Kozioł M, Zhukova L, Goryca K, Poznański J, Wysłouch-Cieszyńska A.

PLoS One. 2016 May 9

http://www.ncbi.nlm.nih.gov/pubmed/27159591

 

Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo.
Gabrysiak M, Wachowska M, Barankiewicz J, Pilch Z, Ratajska A, Skrzypek E, Winiarska M, Domagala A, Rygiel TP, Jozkowicz A, Boon L, Golab J, Firczuk M.

Oncol Rep. 2016 Apr 1

http://www.ncbi.nlm.nih.gov/pubmed/27035643

 

Investigation of cell death mechanisms in human lymphatic endothelial cells undergoing photodynamic therapy.
Wachowska M, Osiak A, Muchowicz A, Gabrysiak M, Domagała A, Kilarski WW, Golab J.

PhotodiagnosisPhotodynTher. 2016 Feb 8.

http://www.ncbi.nlm.nih.gov/pubmed/26868051

 

Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.
Trzeciecka A, Klossowski S, Bajor M, Zagozdzon R, Gaj P, Muchowicz A, Malinowska A, Czerwoniec A, Barankiewicz J, Domagala A, Chlebowska J, Prochorec-Sobieszek M, Winiarska M, Ostaszewski R, Gwizdalska I, Golab J, Nowis D, Firczuk M.

Oncotarget. 2016 Jan 12;7(2):1717-31. doi: 10.18632/oncotarget.6435.

http://www.ncbi.nlm.nih.gov/pubmed/26636537/

 

 

OPEN